Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

Stocks: Insiders Buy at Opko Health and Conn's Inc.

By

Plus, purchases at Synta Pharmaceuticals and General Moly.

PrintPRINT
Welcome to our daily roundup of top insider trades. Here's a look at the most significant inside purchases recently filed with the SEC.

Notable Purchases:
  • W.R. Stephens, Jr., a beneficial owner of specialty retailer Conn's (NASDAQ:CONN) bought 152,746 shares of company stock for $5,992,284. Meanwhile, another beneficial owner, Elizabeth Campbell, bought 106,034 shares for $4,188,343.
  • Bruce Kovner, a director at the biopharmaceutical company Sytna Pharmaceuticals (NASDAQ:SNTA), which develops small molecule drugs for the treatment of cancer and inflammatory diseases, bought 1,250,000 shares of company stock for $5,012,500.
  • Phillip Frost, Chairman and CEO of multinational biopharmaceutical and diagnostics company Opko Health (NYSE:OPK), bought 63,400 shares of company stock for $558,741.
  • Bruce Hansen, CEO of General Moly (NYSEMKT:GMO), a development-stage company in the business of exploring, developing, and mining properties containing molybdenum, bought 140,000 shares of company stock for $128,406. Meanwhile, Vice President and COO Robert Pennington bought 100,000 shares for $96,570.
For more insider trades, see the charts below.

Insider Purchases
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
BO
B
$5,992,284
2
DIR,BO
B
$5,012,500
3
BO
B
$4,188,343
4
O
B
$2,003,859
5
O
B
$1,466,162
6
CEO,CB,BO
B
$558,741
7
BO
B
$500,913
8
CEO,DIR
B
$128,406
9
VP
B
$96,570
10
CEO,DIR,BO
JB*
$76,240

Insider Sales
#: Filer Name Insider Titles Company Name Ticker Trans
Type
Dollar Value
1
CEO,DIR
AS
$2,591,352
2
DIR,BO
AS
$2,075,310
3
DIR
AS
$1,765,118
4
COO,DIR
AS
$1,744,826
5
CEO,DIR,BO
S
$1,499,802
6
CB
S
$1,201,791
7
DIR,BO
S
$1,124,625
8
VP
AS
$1,075,289
9
CEO,PR,DIR
AS
$775,766
10
VP,GC,SEC
AS
$714,532

Source: InsiderInsights.com | Key to Insider Title and Trans Type Codes

An important note from Jonathan Moreland, founder of Insider Insights:

In a victory for common sense, it has been proven profitable -- by both academic studies and (more importantly) the experience of your fellow professional investors -- to monitor the trading behavior of company executives, directors, and large shareholders in the stocks of firms of which they're registered as "insiders."

Please note, however, that the lists above are strictly factual; they are not buy and sell recommendations. Dollar value is only one metric to assess the importance of an insider transaction, and, frankly, often not even the most important metric that determines if an insider transaction is significant.

At InsiderInsights.com, we find new investment ideas just about every day using these and more intricate insider screens to determine where we should focus our subsequent fundamental and technical analysis. And while stocks don't (or shouldn't) move up or down based on insider activity alone, insiders tend to be good indicators of when real stock-moving events like earnings surprises, corporate actions, and new products may be in the offing.

Jonathan Moreland is also the author of "Profit From Legal Insider Trading."
< Previous
  • 1
Next >
No positions in stocks mentioned.
PrintPRINT
 
Featured Videos

WHAT'S POPULAR IN THE VILLE